According to Corcept Therapeutics 's latest financial reports the company's total assets are A$1.33 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | A$1.35 B | 48.14% |
2023-12-31 | A$0.91 B | 6.4% |
2022-12-31 | A$0.85 B | 46.68% |
2021-12-31 | A$0.58 B | -21.39% |
2020-12-31 | A$0.74 B | 26.26% |
2019-12-31 | A$0.58 B | 33.1% |
2018-12-31 | A$0.44 B | 56.63% |
2017-12-31 | A$0.28 B | 196.17% |
2016-12-31 | A$95.38 M | 33.88% |
2015-12-31 | A$71.24 M | 68.37% |
2014-12-31 | A$42.31 M | -40.16% |
2013-12-31 | A$70.71 M | -25.89% |
2012-12-31 | A$95.42 M | 145.64% |
2011-12-31 | A$38.84 M | 57.19% |
2010-12-31 | A$24.71 M | -9.42% |
2009-12-31 | A$27.28 M | -2.65% |
2008-12-31 | A$28.02 M | 38.1% |
2007-12-31 | A$20.29 M | 61.57% |
2006-12-31 | A$12.56 M | -69.52% |
2005-12-31 | A$41.21 M | -33.24% |
2004-12-31 | A$61.73 M | 289.49% |
2003-12-31 | A$15.84 M | -59.03% |
2002-12-31 | A$38.68 M | -18.62% |
2001-12-31 | A$47.53 M |